Renal replacement modality and stroke risk in end-stage renal disease—a national registry study | Zendy

Mark Findlay | Zendy; Rachael MacIsaac | Zendy; Mary Joan MacLeod | Zendy; Wendy Metcalfe | Zendy; Jamie P. Traynor | Zendy; Jesse Dawson | Zendy; Patrick B. Mark | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Renal replacement modality and stroke risk in end-stage renal disease—a national registry study

Author(s) -

Mark Findlay,

Rachael MacIsaac,

Mary Joan MacLeod,

Wendy Metcalfe,

Jamie P. Traynor,

Jesse Dawson,

Patrick B. Mark

Publication year - 2017

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfx291

Subject(s) - medicine , stroke (engine) , renal replacement therapy , dialysis , peritoneal dialysis , end stage renal disease , population , diabetes mellitus , transplantation , incidence (geometry) , kidney disease , hemodialysis , surgery , intensive care medicine , endocrinology , mechanical engineering , physics , environmental health , optics , engineering

The risk of stroke in end-stage renal disease (ESRD) on renal replacement therapy (RRT) is up to 10-fold greater than the general population. However, whether this increased risk differs by RRT modality is unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research